Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.

[1]  L. Aiello.  A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. , 2008, Ophthalmology.

[2]  P. Campochiaro,et al.  Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. , 2006, American journal of ophthalmology.

[3]  J. Duker,et al.  Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. , 2006, Archives of ophthalmology.

[4]  P. Campochiaro,et al.  Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. , 2004, Investigative ophthalmology & visual science.

[5]  Quan Dong Nguyen,et al.  Supplemental oxygen improves diabetic macular edema: a pilot study. , 2004, Investigative ophthalmology & visual science.

[6]  P. Campochiaro,et al.  Quantitative assessment of the integrity of the blood-retinal barrier in mice. , 2002, Investigative ophthalmology & visual science.

[7]  P. Campochiaro,et al.  Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. , 1998, Experimental eye research.

[8]  P. Campochiaro,et al.  Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. , 1997, Histology and histopathology.

[9]  Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. , 1987, Ophthalmology.